Development of Cell Therapy for Duchenne Muscular Dystrophy by iPS Cell-derived Muscle Stem Cell, and Potential of Regenerative Rehabilitation with Cell Therapy-Reference-Cited by-同舟云学术

Development of Cell Therapy for Duchenne Muscular Dystrophy by iPS Cell-derived Muscle Stem Cell, and Potential of Regenerative Rehabilitation with Cell Therapy

Published:2022-10-18 Issue:10 Volume:59 Page:1020-1025
ISSN:1881-3526
Container-title:The Japanese Journal of Rehabilitation Medicine
language:en
Short-container-title:Jpn J Rehabil Med

Author:

Takenaka-Ninagawa Nana¹,Sakurai Hidetoshi¹

Affiliation:

1. 京都大学iPS細胞研究所臨床応用研究部門

Publisher

Japanese Association of Rehabilitation Medicine

Subject

Rehabilitation,Physical Therapy, Sports Therapy and Rehabilitation,General Medicine

Link

https://www.jstage.jst.go.jp/article/jjrmc/59/10/59_59.1020/_pdf

Reference18 articles.

1. 1) Hoffman EP, Brown RH Jr, Kunkel LM：Dystrophin：the protein product of the Duchenne muscular dystrophy locus. Cell 1987；51：919-928

2. 2) Cerletti M, Jurga S, Witczak CA, Hirshman MF, Shadrach JL, Goodyear LJ, Wagers AJ：Highly efficient, functional engraftment of skeletal muscle stem cells in dystrophic muscles. Cell 2008；134：37-47

3. 3) Skuk D, Goulet M, Roy B, Chapdelaine P, Bouchard JP, Roy R, Dugré FJ, Sylvain M, Lachance JG, Deschênes L, Senay H, Tremblay JP：Dystrophin expression in muscles of duchenne muscular dystrophy patients after high-density injections of normal myogenic cells. J Neuropathol Exp Neurol 2006；65：371-386

4. 4) Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S：Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007；131：861-872

5. 5) Zhao M, Tazumi A, Takayama S, Takenaka-Ninagawa N, Nalbandian M, Nagai M, Nakamura Y, Nakasa M, Watanabe A, Ikeya M, Hotta A, Ito Y, Sato T, Sakurai H：Induced Fetal Human Muscle Stem Cells with High Therapeutic Potential in a Mouse Muscular Dystrophy Model. Stem Cell Reports 2020；15：80-94